Understanding complexity in life sciences
The life sciences sector is at the forefront of innovation, spanning pharmaceuticals, biomedical technologies, diagnostics and digital health, animal health, agribusiness and more. Like the global population it serves, the sector is growing,
To meet the challenges of globalisation, consumer demands and fierce competition, the sector is retrofitting, expanding and building new facilities. Projects and programmes can be highly complex, with pressurised timescales and costs to deliver on business plan ambitions fast within this intense commercial environment.
Scientific research campuses, buildings, laboratories and production facilities have to comply with exacting technical, safety and regulatory requirements. These demanding large-scale projects may include a range of building types, from offices to energy centres, and require specialised utility services and zones, such as high containment areas and cleanrooms.
Our expertise in life sciences
We have decades of experience in life sciences and pharmaceutical programme delivery. Our global team is made up of genuine experts, many of whom have worked for life sciences companies, giving us a deep understanding of how to navigate the unique and challenging regulatory landscape within this sector.
We fully understand our clients’ evolving business priorities and operating needs. Through our proven early planning approach, which combines technology, experts, and data, we set projects and programmes on course for success, without compromising speed of delivery.
We can call upon an extensive global library of digitised benchmarking data, market-leading digital tools and best practice learning to drive the highest standards of performance.
Major projects and programmes
We are working with 20 of the 25 largest global pharmaceutical organisations, including Eli Lilly, AstraZeneca, Lonza, Novo Nordisk and Takeda.
Depth of experience
Drawing on our experience across 100s of projects and programmes in life sciences, we bring specialist knowledge of the unique requirements of this fast-paced sector.
We have a multi-disciplinary team of 200 life sciences experts, giving us the reach, specialism and local insight to support global mega-programmes.
Learn how we are working with global clients in pharmaceuticals, biomedical technologies and agribusiness to drive value and efficiency in projects and programmes for advanced scientific research and production facilities.
ONE BioHub, UK
ONE BioHub in Aberdeen is a unique new-build industry innovation hub to drive life sciences commercialisation, company creation and growth.
Integrated COVID Hub North East, UK
Fighting the coronavirus pandemic via a new state-of-the-art testing facility.
UCT Neuroscience Building, South Africa
Improving accessibility and integration for state-of-the-art neurology centre.
Berlin Institute of Health / Berliner Institut für Gesundheitsforschung (BIG), Berlin
Supporting the delivery of an innovation, translational, clinical research and ambulance centre (ATIZ) for the Berlin Institute of Health.
Francis Crick Institute - research facility, London
The Francis Crick Institute is a world-class biomedical research facility on a 3.6 acre brownfield site opposite King’s Cross St Pancras in central London.
Syngenta - commercial controls framework
Reworking commercial control for a major chemical plant
Life sciences perspectives
Find out more about the market moves, trends and best practice in the life sciences sector, as our global team of experts share their in-depth knowledge, views and insights.
Long lead times and rising freight costs challenge Australia and New Zealand’s construction markets
Construction activity across Australia and New Zealand continues at pace, however, long lead times and rising freight costs are placing further pressure on construction markets.
Slow vaccination programmes hamper Australia and New Zealand’s economic recovery
Slow vaccination programmes, rising costs from supply chain pressures and labour shortages create considerable challenges.
Supply chain constraints place pressure on Australia and New Zealand construction markets
Market sentiment has improved across Australia and New Zealand’s construction markets, however this is resulting in competition for resources, amid global supply constraints.
Life sciences services
We help clients meet the challenges of expanding, upgrading or developing facilities, by bringing our experience and expertise to the early stages of project planning.
We support procurement by engaging with the market, to source the most appropriate equipment vendors and suppliers. Our knowledge of the life sciences sector enables us to drive value and performance through robust cost control and project management, while managing and mitigating risk. We understand the importance of validating delivery for business, financial and regulatory reporting processes.
Programme strategy and set up
Our experts bring independent advice and in-depth sector knowledge to establish project and execution plans, realise opportunities and navigate the complexities and risk, setting the project up for success.
Cost and commercial management
We optimise cost performance at every stage by applying our proven methodologies, cost models, data and market intelligence. These approaches drive cost and value through projects and programmes.
Novo Nordisk thoroughly appreciates the partnership we have with Turner & Townsend. This foundation of trust continues to strengthen by consistent, excellent performance from the team and their in-depth knowledge of pharmaceutical capital project management and controls. Morten Nielsen, Senior Vice President Novo Nordisk